Cardiovascular Toxicology is a pivotal journal dedicated to advancing the understanding of the interplay between toxic substances and cardiovascular health. Published by HUMANA PRESS INC, this journal serves as a critical resource for researchers and professionals in the fields of cardiology, toxicology, and molecular biology. With an ISSN of 1530-7905 and an E-ISSN of 1559-0259, it has established itself as a key source of high-quality research since its inception in 2001, continuing to contribute valuable insights through 2024. The journal enjoys a robust reputation, evidenced by its Q2 ranking in both Cardiology and Cardiovascular Medicine and Toxicology, along with a Q3 ranking in Molecular Biology for 2023. With Scopus rankings placing it in the 80th percentile for Cardiology and 71st for Toxicology, Cardiovascular Toxicology attracts submissions that reflect cutting-edge research and innovative methodologies. Notably, the journal prioritizes stringent peer review and scholarly rigor, ensuring that published works significantly impact the understanding of cardiovascular responses to various toxic agents. Though not an open-access journal, its content remains highly sought after in a diverse scholarly community, making it indispensable for those dedicated to enhancing cardiovascular disease prevention, diagnosis, and treatment through toxicological insights.

TOXICOLOGY, published by Elsevier Ireland Ltd, is a prestigious peer-reviewed journal specializing in the field of toxicology. With an ISSN of 0300-483X and an E-ISSN of 1879-3185, this journal provides a vital platform for researchers, professionals, and students to disseminate and access groundbreaking studies from 1973 to present, with a convergence set until 2024. Recognized for its high impact, it holds a Q1 ranking in Toxicology category and ranks #18 out of 133 in Scopus's sector of Pharmacology, Toxicology, and Pharmaceutics, placing it in the 86th percentile. While the journal is not open access, it nonetheless offers a rich collection of research articles that enhance the understanding of toxicological science and its applications. The journal's objectives encompass advancing knowledge in the toxicological evaluation of substances, promoting safety in public health, and fostering dialogue among scholars. As a key resource in the field, TOXICOLOGY plays a crucial role in advancing research and informing practices related to toxicological risks and safety assessments.

Comparative Biochemistry and Physiology C-Toxicology & Pharmacology, published by Elsevier Science Inc, stands as a prominent resource in the fields of pharmacology, toxicology, and biochemical research. With its ISSN 1532-0456 and E-ISSN 1878-1659, this journal has carved out a significant niche, focusing on the comparative aspects of biochemical and physiological data across various species. Recognized for its impact in diverse fields, it boasts a Q1 ranking in Animal Science and Zoology, Aquatic Science, Health, Toxicology and Mutagenesis, alongside respectable standings in other related disciplines. Researchers and professionals can leverage this publication to access high-quality, peer-reviewed studies that advance the understanding of biochemical processes and their toxicological implications. The journal aims to bridge the gap between laboratory findings and real-world applications, fostering an environment for interdisciplinary collaboration. For academics seeking to enhance their knowledge or contribute to this impactful field, Comparative Biochemistry and Physiology C-Toxicology & Pharmacology serves as an invaluable platform.

TOXICOLOGICAL SCIENCES, published by Oxford University Press, is a premier journal in the field of toxicology that has been a cornerstone of scientific discourse since its inception in 1981. With an impressive 2023 impact factor and ranked in the Q1 category for Toxicology, this journal is highly regarded among researchers, professionals, and students dedicated to pharmacology and toxicology. The journal is committed to advancing the understanding of toxicological science, covering a breadth of topics that include the mechanisms of toxicity, risk assessment, and the regulatory aspects affecting public health. With an ISSN of 1096-6080 and an E-ISSN of 1096-0929, TOXICOLOGICAL SCIENCES facilitates open access scholarly work, ensuring that critical research reaches a global audience and promotes collaborative learning. As it converges towards 2024, the journal remains pivotal in shaping the future of toxicology research, providing insights that are essential for developing safer chemicals and protecting environmental health.

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

JOURNAL OF APPLIED TOXICOLOGY, published by Wiley, stands as a leading platform in the field of toxicology, focusing on the rigorous examination of chemical substances and their effects on biological systems. With an impressive Impact Factor, it ranks in the top quartile (Q2) for toxicology journals, reflecting its esteemed position within the scientific community. The journal, identifiable by its ISSN 0260-437X and E-ISSN 1099-1263, has been an invaluable resource since its inception in 1981, and it continues to serve as a conduit for innovative research and practical applications through 2024. Positioned at the forefront of the field, it garners recognition in the Scopus Rankings, where it ranks #31 out of 133 journals in the toxicology category, placing it in the 77th percentile—a testament to its contribution to the advancement of pharmacology and toxicological sciences. While not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students eager to explore cutting-edge findings in applied toxicology, making it a pivotal resource for enhancing knowledge and fostering collaboration in the field.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

CELL BIOLOGY AND TOXICOLOGY, published by SPRINGER, stands as a vital journal within the realms of cell biology and toxicology, boasting an impressive 2023 Q1 ranking in its fields, alongside robust Scopus rankings placing it in the top 11th percentile for Toxicology and the 22nd for Health, Toxicology and Mutagenesis. With an ISSN of 0742-2091 and an E-ISSN of 1573-6822, the journal has been a cornerstone of scientific discourse since its inception in 1984, and will continue to converge innovative research until 2024. The journal focuses on the interplay between cellular mechanisms and toxicological implications, making it an essential resource for researchers, healthcare professionals, and students keen on advancing their understanding of these critical areas. Although it does not offer open access, its high impact and prestigious standing ensure that its publications reach a wide audience dedicated to significant advancements in the life sciences.

Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.

REPRODUCTIVE TOXICOLOGY, published by Pergamon-Elsevier Science Ltd, stands as a pivotal journal in the field of toxicology, specifically focusing on the effects of environmental and pharmaceutical agents on reproductive health. Established in 1987, the journal has a rich history of contributing to the scientific community, and it continues to publish rigorous research and reviews that illuminate the intricate relationships between various toxicants and their reproductive impacts. With an impressive 2023 Q2 ranking in Toxicology and a Scopus ranking of #42 out of 133 in the Toxicology category, REPRODUCTIVE TOXICOLOGY emphasizes high-quality scholarly work that influences both academia and industry practices. Researchers, professionals, and students in toxicology, pharmacology, and public health will find this journal an invaluable resource for staying informed on the latest findings and methodologies in reproductive toxicology. While the journal currently adheres to traditional publishing models without open access options, its authoritative content remains accessible to a global audience interested in advancing the understanding of toxicological impacts on reproduction.